POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UPR_A_1KXA277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	1tmc	CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-AW68) (Homo sapiens)	6 / 10	TYR A   9 ILE A  95 TYR A  99 TYR A 123 ILE A 124 TRP A 147	None	0.49A	81.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UPR_A_1KXA277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	3mbw	EPHRIN-A1 (Homo sapiens)	5 / 10	ILE B  39 VAL B 145 TYR B 127 ILE B  49 TRP B  25	None	1.38A	18.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UPR_A_1KXA277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	3rl2	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 ALPHA CHAIN (Homo sapiens)	5 / 10	ILE A  95 TYR A  99 TYR A 123 ILE A 124 TRP A 147	None	0.35A	87.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UPR_A_1KXA277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	4gah	THIOESTERASE SUPERFAMILY MEMBER 4 (Homo sapiens)	5 / 10	ILE A 188 VAL A 214 SER A 224 TYR A 184 ILE A 182	None	1.07A	18.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UPR_A_1KXA277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	4lcy	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-46 ALPHA CHAIN (Homo sapiens)	6 / 10	TYR A   9 TYR A  99 ASP A 114 TYR A 123 ILE A 124 TRP A 147	None	0.36A	93.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UPR_A_1KXA277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	4uy4	SPINDLIN-4 (Homo sapiens)	5 / 10	ILE A  76 ASP A  92 TYR A  85 ILE A 228 TRP A  49	None	1.28A	20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UPR_A_1KXA277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	5fm5	MYOMESIN-1 (Homo sapiens)	5 / 10	ILE M 528 VAL M 516 SER M 599 ILE M 581 TRP M 556	None	0.95A	21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UPR_A_1KXA277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	5fm8	MYOMESIN-1 (Homo sapiens)	5 / 10	ILE A 528 VAL A 516 SER A 599 ILE A 581 TRP A 556	None	0.98A	15.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UPR_A_1KXA277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	6avf	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-7 ALPHA CHAIN (Homo sapiens)	6 / 10	TYR H   9 TYR H  99 ASP H 114 TYR H 123 ILE H 124 TRP H 147	None	0.43A	65.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UPR_A_1KXA277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	6avo	PROTEASOME SUBUNIT BETA TYPE-10 (Homo sapiens)	5 / 10	ILE B  37 VAL B 100 TYR B 111 TYR B  42 ILE B 178	None	1.27A	13.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UPR_A_1KXA277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	6ces	RAS-RELATED GTP-BINDING PROTEIN C (Homo sapiens)	5 / 10	TYR C 142 ILE C 141 VAL C 143 ASP C 145 ILE C  77	None	1.41A	15.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UPR_C_1KXC277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	1tmc	CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-AW68) (Homo sapiens)	6 / 10	TYR A   9 ILE A  95 TYR A  99 TYR A 123 ILE A 124 TRP A 147	None	0.52A	81.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UPR_C_1KXC277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	3mbw	EPHRIN-A1 (Homo sapiens)	5 / 10	ILE B  39 VAL B 145 TYR B 127 ILE B  49 TRP B  25	None	1.43A	18.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UPR_C_1KXC277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	3rl2	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 ALPHA CHAIN (Homo sapiens)	5 / 10	ILE A  95 TYR A  99 TYR A 123 ILE A 124 TRP A 147	None	0.32A	87.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UPR_C_1KXC277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	4lcy	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-46 ALPHA CHAIN (Homo sapiens)	6 / 10	TYR A   9 TYR A  99 ASP A 114 TYR A 123 ILE A 124 TRP A 147	None	0.36A	93.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UPR_C_1KXC277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	4uy4	SPINDLIN-4 (Homo sapiens)	5 / 10	ILE A  76 ASP A  92 TYR A  85 ILE A 228 TRP A  49	None	1.28A	20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UPR_C_1KXC277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	5fm5	MYOMESIN-1 (Homo sapiens)	5 / 10	ILE M 528 VAL M 516 SER M 599 ILE M 581 TRP M 556	None	0.95A	21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UPR_C_1KXC277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	5fm8	MYOMESIN-1 (Homo sapiens)	5 / 10	ILE A 528 VAL A 516 SER A 599 ILE A 581 TRP A 556	None	0.97A	15.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UPR_C_1KXC277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	6avf	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-7 ALPHA CHAIN (Homo sapiens)	6 / 10	TYR H   9 TYR H  99 ASP H 114 TYR H 123 ILE H 124 TRP H 147	None	0.46A	65.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UPR_C_1KXC277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	6avo	PROTEASOME SUBUNIT BETA TYPE-10 (Homo sapiens)	5 / 10	ILE B  37 VAL B 100 TYR B 111 TYR B  42 ILE B 178	None	1.28A	13.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UPR_C_1KXC277_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	6ces	RAS-RELATED GTP-BINDING PROTEIN C (Homo sapiens)	5 / 10	TYR C 142 ILE C 141 VAL C 143 ASP C 145 ILE C  77	None	1.40A	15.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3VRI_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	1tmc	CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-AW68) (Homo sapiens)	5 / 10	TYR A   9 TYR A  99 TYR A 123 ILE A 124 TRP A 147	None	0.53A	81.14 16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRI_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	4abk	POLY [ADP-RIBOSE] POLYMERASE 14 (Homo sapiens)	5 / 10	TYR A1220 VAL A1212 TYR A1209 ILE A1224 ILE A1348	None	1.35A	22.86 9.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3VRI_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	4lcy	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-46 ALPHA CHAIN (Homo sapiens)	6 / 10	TYR A   9 TYR A  99 ASP A 114 TYR A 123 ILE A 124 TRP A 147	None	0.29A	93.43 4.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3VRI_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	4lcy	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-46 ALPHA CHAIN (Homo sapiens)	6 / 10	TYR A  99 ASP A 114 SER A 116 TYR A 123 ILE A 124 TRP A 147	None	0.73A	93.43 4.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3VRI_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	6avf	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-7 ALPHA CHAIN (Homo sapiens)	6 / 10	TYR H   9 TYR H  99 ASP H 114 TYR H 123 ILE H 124 TRP H 147	None	0.56A	91.07 14.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	1fta	FRUCTOSE-1,6-BISPHOS PHATASE (Homo sapiens)	5 / 12	TYR A 264 ILE A 317 TYR A 215 TYR A 226 ILE A 261	None	1.21A	22.10 7.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 12	ILE A 275 VAL A 271 TYR A 266 ILE A 340 THR A 209	None	1.18A	21.03 4.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	1tmc	CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-AW68) (Homo sapiens)	6 / 12	TYR A   9 ILE A  95 TYR A  99 TYR A 123 ILE A 124 TRP A 147	None	0.51A	81.14 7.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	2r30	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 18 (Homo sapiens)	5 / 12	TYR A  95 ILE A  89 VAL A  79 TRP A 165 ILE A 148	None	1.26A	19.12 18.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	3ch8	FUSION PROTEIN PDZ-FIBRONECTIN (Homo sapiens)	5 / 12	ILE A 173 VAL A 175 TYR A 135 TYR A 139 ILE A 162	None	1.10A	21.63 5.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	3k2m	MONOBODY HA4 (Homo sapiens)	5 / 12	ILE C  75 VAL C  77 TYR C  37 TYR C  41 ILE C  64	None	1.12A	18.15 10.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	3qwq	ADNECTIN (Homo sapiens)	5 / 12	ILE B  70 VAL B  72 TYR B  32 TYR B  36 ILE B  59	None	1.13A	17.87 8.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	3qwr	ADNECTIN (Homo sapiens)	5 / 12	ILE D  70 VAL D  72 TYR D  32 TYR D  36 ILE D  59	None	1.10A	17.87 8.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	3rl2	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 ALPHA CHAIN (Homo sapiens)	5 / 12	ILE A  95 TYR A  99 TYR A 123 ILE A 124 TRP A 147	None	0.34A	87.59 23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	4gah	THIOESTERASE SUPERFAMILY MEMBER 4 (Homo sapiens)	5 / 12	ILE A 188 VAL A 214 SER A 224 TYR A 184 ILE A 182	None	1.08A	18.47 7.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	4lcy	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-46 ALPHA CHAIN (Homo sapiens)	5 / 12	ASP A 114 SER A 116 TYR A 123 ILE A 124 TRP A 147	None	0.78A	93.43 23.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	4lcy	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-46 ALPHA CHAIN (Homo sapiens)	6 / 12	TYR A   9 TYR A  99 ASP A 114 TYR A 123 ILE A 124 TRP A 147	None	0.23A	93.43 23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	5dc4	AS25 MONOBODY (Homo sapiens)	5 / 12	ILE B  72 VAL B  74 TYR B  34 TYR B  38 ILE B  61	None	1.08A	15.69 7.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	5fm5	MYOMESIN-1 (Homo sapiens)	5 / 12	ILE M 528 VAL M 516 SER M 599 ILE M 581 TRP M 556	None	0.99A	22.50 7.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	5fm8	MYOMESIN-1 (Homo sapiens)	5 / 12	ILE A 528 VAL A 516 SER A 599 ILE A 581 TRP A 556	None	1.02A	15.48 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	5fv2	VH DOMAIN ANTIBODY (Homo sapiens)	5 / 12	VAL A  48 SER A  49 TYR A  60 ILE A  70 THR A 110	None	1.25A	18.65 9.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	5nkq	MONOBODY (Homo sapiens)	5 / 12	ILE E  71 VAL E  73 TYR E  33 TYR E  37 ILE E  60	None	1.20A	15.64 11.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	6avf	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-7 ALPHA CHAIN (Homo sapiens)	6 / 12	TYR H   9 TYR H  99 ASP H 114 TYR H 123 ILE H 124 TRP H 147	None	0.51A	91.07 8.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	6avo	PROTEASOME SUBUNIT BETA TYPE-10 (Homo sapiens)	5 / 12	ILE B  37 VAL B 100 TYR B 111 TYR B  42 ILE B 178	None	1.26A	13.04 6.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	6b2b	MONOBODY (Homo sapiens)	5 / 12	ILE C  71 VAL C  73 TYR C  33 TYR C  37 ILE C  60	None	1.10A	14.55 11.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	6byn	WDR5-BINDING MONOBODY, MB(S4) (Homo sapiens)	5 / 12	ILE M  70 VAL M  72 TYR M  32 TYR M  36 ILE M  59	None	1.12A	15.85 11.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5U98_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	1tmc	CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-AW68) (Homo sapiens)	6 / 10	TYR A   9 ILE A  95 TYR A  99 TYR A 123 ILE A 124 TRP A 147	None	0.48A	81.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U98_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	3mbw	EPHRIN-A1 (Homo sapiens)	5 / 10	ILE B  39 VAL B 145 TYR B 127 ILE B  49 TRP B  25	None	1.39A	18.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5U98_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	3rl2	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 ALPHA CHAIN (Homo sapiens)	5 / 10	ILE A  95 TYR A  99 TYR A 123 ILE A 124 TRP A 147	None	0.37A	87.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U98_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	4gah	THIOESTERASE SUPERFAMILY MEMBER 4 (Homo sapiens)	5 / 10	ILE A 188 VAL A 214 SER A 224 TYR A 184 ILE A 182	None	1.10A	18.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5U98_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	4lcy	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-46 ALPHA CHAIN (Homo sapiens)	5 / 10	ASP A 114 SER A 116 TYR A 123 ILE A 124 TRP A 147	None	0.84A	93.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5U98_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	4lcy	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-46 ALPHA CHAIN (Homo sapiens)	6 / 10	TYR A   9 TYR A  99 ASP A 114 TYR A 123 ILE A 124 TRP A 147	None	0.36A	93.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U98_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	4uy4	SPINDLIN-4 (Homo sapiens)	5 / 10	ILE A  76 ASP A  92 TYR A  85 ILE A 228 TRP A  49	None	1.26A	20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U98_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	5fm5	MYOMESIN-1 (Homo sapiens)	5 / 10	ILE M 528 VAL M 516 SER M 599 ILE M 581 TRP M 556	None	0.94A	21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U98_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	5fm8	MYOMESIN-1 (Homo sapiens)	5 / 10	ILE A 528 VAL A 516 SER A 599 ILE A 581 TRP A 556	None	0.96A	15.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5U98_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	6avf	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-7 ALPHA CHAIN (Homo sapiens)	6 / 10	TYR H   9 TYR H  99 ASP H 114 TYR H 123 ILE H 124 TRP H 147	None	0.43A	65.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U98_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	6avo	PROTEASOME SUBUNIT BETA TYPE-10 (Homo sapiens)	5 / 10	ILE B  37 VAL B 100 TYR B 111 TYR B  42 ILE B 178	None	1.28A	13.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U98_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	6ces	RAS-RELATED GTP-BINDING PROTEIN C (Homo sapiens)	5 / 10	TYR C 142 ILE C 141 VAL C 143 ASP C 145 ILE C  77	None	1.40A	15.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5U98_D_1KXD301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	1tmc	CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-AW68) (Homo sapiens)	6 / 10	TYR A   9 ILE A  95 TYR A  99 TYR A 123 ILE A 124 TRP A 147	None	0.48A	81.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U98_D_1KXD301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	3mbw	EPHRIN-A1 (Homo sapiens)	5 / 10	ILE B  39 VAL B 145 TYR B 127 ILE B  49 TRP B  25	None	1.43A	18.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5U98_D_1KXD301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	3rl2	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 ALPHA CHAIN (Homo sapiens)	5 / 10	ILE A  95 TYR A  99 TYR A 123 ILE A 124 TRP A 147	None	0.37A	87.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U98_D_1KXD301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	4gah	THIOESTERASE SUPERFAMILY MEMBER 4 (Homo sapiens)	5 / 10	ILE A 188 VAL A 214 SER A 224 TYR A 184 ILE A 182	None	1.09A	18.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5U98_D_1KXD301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	4lcy	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-46 ALPHA CHAIN (Homo sapiens)	6 / 10	TYR A   9 TYR A  99 ASP A 114 TYR A 123 ILE A 124 TRP A 147	None	0.34A	93.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U98_D_1KXD301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	4uy4	SPINDLIN-4 (Homo sapiens)	5 / 10	ILE A  76 ASP A  92 TYR A  85 ILE A 228 TRP A  49	None	1.29A	20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U98_D_1KXD301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	5fm5	MYOMESIN-1 (Homo sapiens)	5 / 10	ILE M 528 VAL M 516 SER M 599 ILE M 581 TRP M 556	None	0.96A	21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U98_D_1KXD301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	5fm8	MYOMESIN-1 (Homo sapiens)	5 / 10	ILE A 528 VAL A 516 SER A 599 ILE A 581 TRP A 556	None	0.99A	15.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5U98_D_1KXD301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	6avf	HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-7 ALPHA CHAIN (Homo sapiens)	6 / 10	TYR H   9 TYR H  99 ASP H 114 TYR H 123 ILE H 124 TRP H 147	None	0.42A	65.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U98_D_1KXD301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	6avo	PROTEASOME SUBUNIT BETA TYPE-10 (Homo sapiens)	5 / 10	ILE B  37 VAL B 100 TYR B 111 TYR B  42 ILE B 178	None	1.27A	13.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U98_D_1KXD301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN)	6ces	RAS-RELATED GTP-BINDING PROTEIN C (Homo sapiens)	5 / 10	TYR C 142 ILE C 141 VAL C 143 ASP C 145 ILE C  77	None	1.41A	15.73